InfuSystem Holdings Inc  

(Public, NYSEMKT:INFU)   Watch this stock  
Find more results for NYSEAMEX:INFU
3.26
+0.10 (3.16%)
Apr 24 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 3.19 - 3.26
52 week 2.43 - 4.50
Open 3.22
Vol / Avg. 65,572.00/42,856.00
Mkt cap 72.73M
P/E 22.00
Div/yield     -
EPS 0.15
Shares 22.31M
Beta 0.58
Inst. own 77%
May 4, 2015
Q1 2015 InfuSystem Holdings Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Mar 9, 2015
Q4 2014 InfuSystem Holdings Inc Earnings Call
Mar 9, 2015
Q4 2014 InfuSystem Holdings Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 6.37% 5.05%
Operating margin 17.06% 14.03%
EBITD margin - 23.27%
Return on average assets 5.15% 4.26%
Return on average equity 9.06% 7.53%
Employees 222 -
CDP Score - -

Address

31700 Research Park Dr
MADISON HEIGHTS, MI 48071-4627
United States - Map
+1-248-2911210 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

InfuSystem Holdings, Inc. is a provider of infusion pumps and related services. Through its subsidiaries, the Company provides services to hospitals, oncology practices and facilities, and other health care providers. The Company�s core service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics to be utilized in the treatment of cancers including colorectal cancer. The Company provides pumps and related supplies to oncology clinics, obtain an assignment of insurance benefits from the patient, and bill the patient�s insurance company or patient, for the use of the pump and supplies, and collect payment. The Company provides pump management services for the pumps and associated disposable supply kits to approximately 1,800 oncology clinics. The Company sells, rents and leases new and pre-owned pole mounted and ambulatory infusion pumps to oncology practices.

Officers and directors

Eric Steen President, Chief Executive Officer, Director
Age: 57
Bio & Compensation  - Reuters
Jonathan P. Foster Chief Financial Officer
Age: 50
Bio & Compensation  - Reuters
Janet Skonieczny Chief Operating Officer, Chief Compliance Officer and Privacy Officer
Age: 55
Bio & Compensation  - Reuters
Michael Milton McReynolds Chief Information Officer
Age: 45
Bio & Compensation  - Reuters
Thomas F. Creal II Executive Vice President of First Biomedical
Age: 66
Bio & Compensation  - Reuters
Ryan J. Morris Non-Executive Chairman of the Board
Age: 30
Bio & Compensation  - Reuters
Gregg O. Lehman Ph.D. Director
Age: 66
Bio & Compensation  - Reuters
David C. Dreyer CPA Independent Director
Age: 58
Bio & Compensation  - Reuters
Joseph E. Whitters Independent Director
Age: 56
Bio & Compensation  - Reuters
Wayne P. Yetter Independent Director
Age: 70
Bio & Compensation  - Reuters